FDA Inspection 1209601 — Janssen Research And Development, LLC

Janssen Research And Development, LLC — FEI 3027037370

The FDA completed an inspection of Janssen Research And Development, LLC on Jun 16, 2023 in Somerville, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Jun 16, 2023
Fiscal Year
2023
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Somerville, NJ (United States)

Additional details

Sponsor, Contract Research Organization

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.